WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Outset Medical you have until Septemto petition the court for lead plaintiff status. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's flagship product, Tablo Hemodialysis System ("Tablo"), would require an additional 510(k) application to be filed with The United States Food and Drug Administration ("FDA"), as defendants had "continuously made improvements and updates to Tablo over time since its original clearance" (2) as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols (3) the Company's inability to conduct the human factors study subjected the Company to the likelihood of the FDA imposing a "shipment hold" and marketing suspension, leaving the Company unable to sell Tablo for home use and (4) as a result, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and /or lacked a reasonable basis at all relevant times. Learn more about your recoverable losses in OM:ĬLASS ACTION CASE DETAILS: The filed complaint alleges that Outset Medical, Inc. Lead Plaintiff Deadline: September 6, 2022 This lawsuit is on behalf of all persons or entities who purchased Outset Medical common stock between September 15, 2020, and June 13, 2022. (NASDAQ: OM) alleging that the Company violated federal securities laws. 6, 2022 /PRNewswire/ - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Outset Medical, Inc. Handle all communications and administrative follow-up.NEW YORK, Sept.Develop expert level knowledge of Dialysis.Develop initial contact with CEO and senior leadership.Build Tablo support teams in each Tablo location.Effectively manage transition of initial sale and installation driving procedural volume and growth.Identify key institutions, generate market awareness, and drive sales of the Tablo within an assigned sales territory.Build support from physicians, clinical staff and administration for Tablo.Build clinical and administrative support through technical presentations, executive meetings, marketing events and Tablo demos.
Manage and support the complex sales process.
Area Sales Managers are expected to provide an extraordinary degree of information gathering and presenting to buying teams throughout the capital equipment purchasing process. This requires a number of capabilities including expert-level knowledge in the capital sales process, the ability to build a team of advocates within each facility, strong solution selling skills, and enough tenacity to insure sales objectives are met on a consistent basis.
The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care.Īn Area Sales Manager is responsible for supporting the sale of the Tablo in new and existing locations. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.
0 kommentar(er)
